menu
    • menu

    Company profile for Cocrystal Pharma

    NEW Drugs in Dev: 6
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis C viruses, influenza viruses, noroviruses and coronaviruses. We employ unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The Company is developing CC-31244, an investigational, oral, bro...
    Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis C viruses, influenza viruses, noroviruses and coronaviruses. We employ unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The Company is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cocrystal PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    19805 N. Creek Parkway Bothell, WA 98011
    Telephone
    Telephone
    877-COCP123
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cocrystalpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cocrystal-pharma-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cocrystalpharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cocrystal Pharma Showcases CDI-988 Progress For Norovirus
    Cocrystal Pharma Showcases CDI-988 Progress For Norovirus

    30 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7257116

    FIRSTWORD PHARMA
    30 Apr 2026
    Share Share
    Cocrystal Gets FDA Fast Track for CDI-988 for Norovirus
    Cocrystal Gets FDA Fast Track for CDI-988 for Norovirus

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267307/0/en/Cocrystal-Pharma-Receives-FDA-Fast-Track-Designation-for-CDI-988-for-Norovirus-Infection-Treatment-and-Preventive.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Cocrystal Pharma Reveals 2025 Financials, Updates Antiviral Drug
    Cocrystal Pharma Reveals 2025 Financials, Updates Antiviral Drug

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265429/0/en/Cocrystal-Pharma-Reports-2025-Financial-Results-and-Provides-Updates-on-its-Antiviral-Drug-Development-Programs.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Cocrystal Pharma Initiates Phase 1B Study On CDI-988
    Cocrystal Pharma Initiates Phase 1B Study On CDI-988

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251781/0/en/First-Subjects-Dosed-in-Cocrystal-Pharma-s-Phase-1b-Study-Evaluating-CDI-988-for-Norovirus-Prevention-and-Treatment.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Cocrystal’s First Oral Norovirus Protease Inhibitor CDI-988
    Cocrystal’s First Oral Norovirus Protease Inhibitor CDI-988

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241010/0/en/Cocrystal-Pharma-s-First-Oral-Norovirus-Protease-Inhibitor-CDI-988-to-be-Featured-at-the-International-Society-for-Antiviral-Research-Conference-ICAR-2026.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Cocrystal Pharma Gets Emory Med School Approval For CDI-988
    Cocrystal Pharma Gets Emory Med School Approval For CDI-988

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207637/0/en/Cocrystal-Pharma-Receives-IRB-Approval-from-Emory-University-School-of-Medicine-for-Phase-1b-Human-Challenge-Study-with-CDI-988-for-Prevention-and-Treatment-of-Norovirus.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search